Abbott Laboratories buy Benchmark Co.
Start price
10.10.25
/
50%
€115.06
Target price
10.10.26
€125.35
Performance (%)
-19.87%
Price
22:29
€92.20
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.87%. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.376% | 1.376% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat